v3.25.2
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Conversion of notes payable to Common Stock
Conversion of Series A Preferred Stock to Common Stock
Series A Preferred Stock
Series A Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Common Stock
Common Stock
Conversion of notes payable to Common Stock
Common Stock
Conversion of Series A Preferred Stock to Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of notes payable to Common Stock
Additional Paid-in Capital
Conversion of Series A Preferred Stock to Common Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2023       0   1,389,884              
Beginning Balance at Dec. 31, 2023 $ (41,786,850)     $ 0   $ 139     $ 77,004,714     $ 0 $ (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 1,339,965               1,339,965        
Vesting of RSUs (in shares)           90,587              
Vesting of RSUs 0         $ 9     (9)        
Exercise of warrants (in shares)           615,589              
Exercise of warrants 4,451,162         $ 61     4,451,101        
Conversion of stock (in shares)           628,942              
Conversion of stock 3,485,645         $ 63     3,485,582        
At the Market (ATM) share offering (in shares)           1,406,424              
At the Market (ATM) share offering 9,357,954         $ 141     9,357,813        
Net loss (68,297,961)                       (68,297,961)
Ending Balance (in shares) at Jun. 30, 2024       0   4,131,426              
Ending Balance at Jun. 30, 2024 (91,450,085)     $ 0   $ 413     95,639,166     0 (187,089,664)
Beginning Balance (in shares) at Dec. 31, 2023       0   1,389,884              
Beginning Balance at Dec. 31, 2023 (41,786,850)     $ 0   $ 139     77,004,714     0 (118,791,703)
Ending Balance (in shares) at Dec. 31, 2024       35,034   9,761,895              
Ending Balance at Dec. 31, 2024 (20,397,413)     $ 4   $ 976     233,342,188     (42,229) (253,698,352)
Beginning Balance (in shares) at Mar. 31, 2024       0   1,592,140              
Beginning Balance at Mar. 31, 2024 (112,755,477)     $ 0   $ 159     78,875,003     0 (191,630,639)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 809,310               809,310        
Vesting of RSUs (in shares)           46,665              
Vesting of RSUs 0         $ 5     (5)        
Exercise of warrants (in shares)           457,255              
Exercise of warrants 3,111,508         $ 45     3,111,463        
Conversion of stock (in shares)           628,942              
Conversion of stock 3,485,645         $ 63     3,485,582        
At the Market (ATM) share offering (in shares)           1,406,424              
At the Market (ATM) share offering 9,357,954         $ 141     9,357,813        
Net loss 4,540,975                       4,540,975
Ending Balance (in shares) at Jun. 30, 2024       0   4,131,426              
Ending Balance at Jun. 30, 2024 (91,450,085)     $ 0   $ 413     95,639,166     0 (187,089,664)
Beginning Balance (in shares) at Dec. 31, 2024       35,034   9,761,895              
Beginning Balance at Dec. 31, 2024 (20,397,413)     $ 4   $ 976     233,342,188     (42,229) (253,698,352)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 570,015               570,015        
Vesting of RSUs (in shares)           165,958              
Vesting of RSUs 0         $ 17     (17)        
Conversion of stock (in shares)         (16,738)   1,805,392 18,163,361          
Conversion of stock 0 $ 2,870,573 $ (2)   $ (2)   $ 181 $ 1,815   $ 2,870,392 $ (1,815)    
At the Market (ATM) share offering (in shares)           7,488,822              
At the Market (ATM) share offering 19,438,121         $ 749     19,437,372        
Earnout shares (contingent) 6,864,729               6,864,729        
Other (in shares)           19,520              
Other 0         $ 1     (1)        
Net loss (15,021,363)                       (15,021,363)
Ending Balance (in shares) at Jun. 30, 2025       18,296   37,404,948              
Ending Balance at Jun. 30, 2025 (5,675,340)     $ 2   $ 3,739     263,082,863     (42,229) (268,719,715)
Beginning Balance (in shares) at Mar. 31, 2025       19,846   35,153,188              
Beginning Balance at Mar. 31, 2025 1,521,502     $ 2   $ 3,515     262,825,753     (42,229) (261,265,539)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 257,334               257,334        
Vesting of RSUs (in shares)           106,610              
Vesting of RSUs 0         $ 10     (10)        
Conversion of stock (in shares)         (1,550)     2,145,150          
Conversion of stock     $ 0         $ 214     $ (214)    
Net loss (7,454,176)                       (7,454,176)
Ending Balance (in shares) at Jun. 30, 2025       18,296   37,404,948              
Ending Balance at Jun. 30, 2025 $ (5,675,340)     $ 2   $ 3,739     $ 263,082,863     $ (42,229) $ (268,719,715)